Home

KEYNOTE SPEAKERS

Robert K. DeConti, JD

Chief Counsel to the Inspector General, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Kristy Grant-Hart, JD, CCEP-I

Founder and CEO, Spark Compliance; Former Chief Compliance Officer, United International Pictures; Director of Compliance, Europe, MEA, Carlson Wagonlit Travel, Los Angeles, CA

Catherine (Katie) Gray, PharmD

Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Geoffrey S. Martha

Chairman and Chief Executive Officer, Medtronic, Minneapolis, MN

Lisa Miller, JD

Deputy Assistant Attorney General, Fraud and Appellate Sections, Criminal Division, US Department of Justice, Washington, DC

Mary E. Riordan, JD

Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Richard Simkin

Chief Commercial Officer, Indivior; Former President North America, Reckitt Benckiser Pharmaceuticals, Richmond, VA

FEATURED FACULTY

Suneal Bedi, JD, PhD

Assistant Professor OF Business Law & Ethic, Kelley School of Business, Indiana University, Bloomington, IN

Eric Bolesh

Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

Eve M. Brunts, JD, LLM

Partner, Ropes & Gray, Boston, MA

Terra Buckley, JD

Vice President, Head of Compliance Advisory Services, MedPro Systems, Summit, NJ

Cindy Cetani, LPEC

Chief Integrity & Compliance Officer, Indivior; Former Group Integrity & Compliance, Head, Compliance Operations, Novartis, Glen Allen, VA

Greg Demske, JD

Partner, Goodwin Procter LLP; Former Chief Counsel, HHS Office of Inspector General, Washington, DC

Stefanie A. Doebler, JD

Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP, Washington, DC

J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US

Managing Director, Epsilon Life Sciences LLC, Atlanta, GA

Ronald N. Feldman

President and Creative Director, Learnings & Entertainments, Chicago, IL

Alison Fethke, JD

Counsel, Ropes & Gray, LLP, Former Counsel, Legal Regulatory & Compliance, Abbvie, Chicago, IL

Pat Fogarty, JD

Deputy General Counsel & Senior Vice President of Legal, AdvaMed; Former Compliance Officer & Assistant General Counsel, BIO, Washington, DC

Sarah A. Franklin, JD

Partner and Vice-chair, Life Sciences Investigations Practice, Covington & Burling LLP, Washington, DC

Gary F. Giampetruzzi, JD

Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant GC, Pfizer, New York, NY

Margaux J. Hall, JD

Partner, Ropes & Gray, LLP, Washington, DC

Todd Haugh, JD

Associate Professor of Business Law and Ethics, Indiana University, Bloomington, IN

Emily F. Hodge, JD

Partner, Choate, Hall & Stewart LLP, Boston, MA

Jocelyn Lafond, LLB, LLM

Vice President, General Counsel and Corporate Secretary, Theratechnologies, Montreal, Quebec, Canada

Angelique Lee, JD

Vice President, Global Chief Compliance & Ethics Officer, Jazz Pharmaceuticals, Carlsbad, CA

Michael K. Loucks, JD

Partner, Skadden, Arps, Slate, Meagher & Flom LLP; Former Acting US Attorney, Massachusetts, US Department of Justice, Boston, MA

Kirsten Mayer, JD

Interim Legal Director, ACLU of Massachusetts; Former Head, US Compliance & VP Legal, argenx; Former Partner, Ropes & Gray LLP, Boston, MA

Kevin McAnaney, JD

Law Office of Kevin McAnaney; Former Chief, Industry Guidance Branch, HHS Office of Counsel to the Inspector General, Bethesda, MD

Daniel O’Connor

Senior Vice President, NXLevel Compliance, Lambertville, NJ

Nikki Reeves, JD

Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

Jeff Rosenbaum, MBA

Partner & Co-Founder, Dovetail Consulting Group; Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA

Ann-Marie Tejcek, MA

Associate Vice President Global Medical Affairs, Strategy & Transformation, Eli Lilly, Indianapolis, IN

Gregg Shapiro, JD

Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA

Michael L. Shaw, JD

Principal, Global Head of Risk & Compliance, ZS; Former Vice President and Compliance Officer, Global Therapy Areas and US Pharma, GlaxoSmithKline, Princeton, NJ

James Sheehan, JD

Chief, Charities Bureau at Attorney General of New York; Former Chief Integrity Officer, City of New York Human Resources Administration; Former NY Medicaid Inspector General; Former Associate United States Attorney, Eastern District of Pennsylvania, New York, NY

Paul Silver

Principal and Corporate Intelligence Services Practice Leader, Deloitte Advisory, Atlanta, GA

L. Stephan Vincze, JD, LLM, MBA

President & CEO, TRESTLE Compliance; Former Sr. VP and CCO, Warner Chilcot; Former VP, Ethics & Compliance Officer, TAP Pharmaceutical, Boston, MA

Julie Ritchie Wagner, JD

Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

PCF EXECUTIVE COMMITTEE

Joseph Zimmerman

Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics (PCF Chair)

Christie Camelio

Chief Compliance and Risk Officer, EQRx

Jill Dailey, JD

Vice President & Chief Compliance Officer, Incyte

Cheryl Lee, MBA

Vice President, Head of Major Markets Compliance & Ethics, Bristol Myers Squibb

Joshua Marks, JD

Global Head of Ethics & Compliance Program and Governance, Takeda Pharmaceuticals

Donna White, CCEP

Vice President, Compliance Officer, Chiesi

MEDICAL DEVICE STEERING COMMITTEE CO CHAIRS

Sujata Dayal, JD

Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Tara Shewchuk, JD

Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD

Vice President Compliance, Commercial Divisions, Stryker